Xtampza er and Itching - a phase IV clinical study of FDA data

Summary:

Itching is reported as a side effect among people who take Xtampza er (oxycodone), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Gabapentin, and have Pain.

The phase IV clinical study analyzes which people have Itching when taking Xtampza er. It is created by eHealthMe based on reports of 1,467 people who have side effects when taking Xtampza er from the FDA, and is updated regularly.

What is Xtampza er?

Xtampza er has active ingredients of oxycodone. eHealthMe is studying from 1,502 Xtampza er users. Check the latest studies of Xtampza er.

What is Itching?

Itching is found to be associated with 3,211 drugs and 4,536 conditions by eHealthMe. Check the latest studies of Itching.

On Jul, 15, 2026

1,467 people reported to have side effects when taking Xtampza er.
Among them, 56 people (3.82%) have Itching.

Among these 56 people:

How long have people been on Xtampza er when they have Itching? *

What is the gender of people who have Itching when taking Xtampza er? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Itching when taking Xtampza er? *

What are other drugs people take besides Xtampza er? *

What are other side effects people have besides Itching? *

Rashes (redness): 14 people, 25.00%
Nausea (feeling of having an urge to vomit): 7 people, 12.50%
Urticaria (rash of round, red welts on the skin that itch intensely): 6 people, 10.71%
Pain: 5 people, 8.93%
Drug Ineffective: 5 people, 8.93%
Skin Exfoliation (removal of the oldest dead skin cells): 4 people, 7.14%
Headache (pain in head): 4 people, 7.14%
Dehydration (dryness resulting from the removal of water): 4 people, 7.14%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 7.14%
Rash Erythematous (redness of the skin): 3 people, 5.36%

What are the existing conditions these people have? *

Pain: 14 people, 25.00%
Back Pain: 4 people, 7.14%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 3 people, 5.36%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 5.36%
Breakthrough Pain: 2 people, 3.57%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 2 people, 3.57%
High Blood Pressure: 2 people, 3.57%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 3.57%
Joint Pain: 2 people, 3.57%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 2 people, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Xtampza er and have Itching?

- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xtampza er:

Xtampza er (1,502 reports)

Itching treatments and more:

Itching (398,821 reports)

Browse all side effects of Xtampza er:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Itching:

Itching (3,211 drugs)

Browse all the conditions that are associated with Itching:

Itching (4,536 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone (the active ingredients of Xtampza er) and Xtampza er (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.